Last Updated: 02/12/2024

Assessment of PfCSP immunogens 153-155 in non-human primates

Objectives

The aim of this project is to support the development of 2nd generation malaria vaccine candidates.

Principal Institution

Karolinska Institute (KI), Sweden

Principal Investigators / Focal Persons

Karin Lore

Themes

Immunology

Date

Nov 2022 — Mar 2024

Total Project Funding

$967,178

Funding Details
Country / Project Site(s)

Sweden

SHARE
SHARE